MicroRNA-326 Negatively Regulates CD155 Expression in Lung Adenocarcinoma
Takayuki Nakanishi(Kyushu University), Isamu Okamoto(Kyushu University Hospital)
Cited by 0
Related Papers
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
|Science Translational Medicine|2011|670
Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with <i>EGFR</i> Mutations
|Clinical Cancer Research|2009|189
Activation of HER Family Signaling as a Mechanism of Acquired Resistance to ALK Inhibitors in EML4-ALK–Positive Non–Small Cell Lung Cancer
|Clinical Cancer Research|2012|156
The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer
|Oncogene|2013|143
Intrinsic and Extrinsic Regulation of PD-L2 Expression in Oncogene-Driven Non–Small Cell Lung Cancer
|Journal of Thoracic Oncology|2018|38